Cargando…
APC selectively mediates response to chemotherapeutic agents in breast cancer
BACKGROUND: The Adenomatous Polyposis Coli (APC) tumor suppressor is mutated or hypermethylated in up to 70 % of sporadic breast cancers depending on subtype; however, the effects of APC mutation on tumorigenic properties remain unexplored. Using the Apc(Min/+) mouse crossed to the Polyoma middle T...
Autores principales: | VanKlompenberg, Monica K., Bedalov, Claire O., Soto, Katia Fernandez, Prosperi, Jenifer R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458029/ https://www.ncbi.nlm.nih.gov/pubmed/26049416 http://dx.doi.org/10.1186/s12885-015-1456-x |
Ejemplares similares
-
Erratum to: APC selectively mediates response to chemotherapeutic agents in breast cancer
por: VanKlompenberg, Monica K., et al.
Publicado: (2016) -
APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation
por: VanKlompenberg, Monica K., et al.
Publicado: (2017) -
Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
por: Stefanski, Casey D., et al.
Publicado: (2020) -
Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells
por: Astarita, Emily M., et al.
Publicado: (2021) -
APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells
por: Stefanski, Casey D., et al.
Publicado: (2019)